Articles From: - Fox, Green Mountain on tap to report earnings after hours to - Celsus Therapeutics Plc Announces First Patient Enrolled in Phase II Trial of MRX-6 in Pediatric Atopic Dermatitis


By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- 21st Century Fox Inc. shares are expected to be active in Wednesday's after-hours trading with the media company scheduled to announce its quarterly results.
Sign-up for - Fox, Green Mountain on tap to report earnings after hours investment picks
The Graystone Company (OTC: GYST) announced today that the Company’s mining operations generated approximately 735 grams of gold during the time period of July 1, 2014 through July 26, 2014.
Sign-up for - Graystone July Production Results investment picks
PITTSBURGH , Aug.
Sign-up for - MSA to Present at Jefferies Global Industrials Conference investment picks
2014/8/6
Rigrodsky & Long, P.A.: Do you own shares of GFI Group Inc. (NYSE: GFIG )? Did you purchase any of your shares prior to July 30, 2014?
Sign-up for 2014/8/6 - GFI GROUP INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/8/6
NASDAQ: CRME TSX: COM VANCOUVER , Aug.
Sign-up for 2014/8/6 - Cardiome To Present At Canaccord Genuity Growth Conference On August 13 investment picks
By Jon Friedman, MarketWatch Opinion: Time for cable-news channel to earn some respect -Jon Friedman; 415-439-6400; AskNewswires@dowjones.com NEW YORK (MarketWatch) -- It's time for CNN to put up or shut up.
Sign-up for - CNN: Put up or (please) shut up investment picks
2014/8/6
By Carla Mozee, MarketWatch Merger news, earnings for stocks -Carla Mozee; 415-439-6400; AskNewswires@dowjones.com LONDON (MarketWatch) -- Iliad SA and Telecom Italia SpA were among the biggest stock movers in European trade Wednesday.
Sign-up for 2014/8/6 - UPDATE: Iliad, Telecom Italia among key European movers investment picks
http://media.marketwire.com/attachments/201204/33223_ACPHS-logoL-RGB300dpi.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135898&ProfileId=051205&sourceType=1 ALBANY, NY --
Sign-up for - Albany Molecular Research Inc. Co-Founder Thomas D'Ambra Joins ACPHS Board of Trustees investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135922&ProfileId=051205&sourceType=1 ABERDEEN, SCOTLAND --
Sign-up for - Ithaca Energy Inc Announces Holding(s) in Company investment picks
2014/8/6
DUNMORE, Pa.
Sign-up for 2014/8/6 - Fidelity D & D Bancorp, Inc. Third Quarter 2014 Dividend investment picks
2014/8/6
Energy Savings Achieved through Ultraviolet Light Sterilization.
Sign-up for 2014/8/6 - SurePure's Photopurification Technology Demonstrates Energy Savings to the Brewing Industry through its Collaboration with SAB Miller investment picks
By Sam Schechner PARIS--France's Iliad SA sees no immediate need to boost its $15 billion bid for control of T-Mobile US Inc. after the collapse of a potential rival offer from Sprint Corp., a person familiar with the matter said on Wednesday.
Sign-up for - Iliad to forge ahead with T-Mobile bid investment picks
-- Company Executes Restructuring Support Agreement and Files Prepackaged Plan of Reorganization for Parent with Overwhelming Lender Support -- --
Sign-up for - Eagle Bulk Shipping Inc. Reaches Agreement With Lenders To Significantly Reduce Debt And Strengthen Balance Sheet investment picks
Level 3 Offers Broad Portfolio of Network Services for Public Sector Agencies to Improve and Secure Statewide Communications BROOMFIELD, Colo.
Sign-up for - Commonwealth of Massachusetts Adds Level 3 to Statewide ITT46 Network Services Contract investment picks
By Colum Murphy and Eva Dou Chinese antitrust regulators are intensifying pressure on foreign technology and auto companies in separate moves that experts say show Beijing's desire to give Chinese companies greater heft in their dealings with foreign firms.
Sign-up for - China regulator probes Microsoft, Accenture offices investment picks
2014/8/6
Intelsat S.A. (NYSE: I), the world’s leading provider of satellite services, today announced that Orange Niger, part of the Orange Group, is utilizing Intelsat capacity to expand its cellular network to the rural regions of Niger.
Sign-up for 2014/8/6 - Orange Niger Expands Relationship with Intelsat, Extending the Reach of its Cellular Network in Rural Niger investment picks
Health Net, Inc. (NYSE: HNT) today announced 2014 second quarter GAAP net income of $120.9 million, or $1.49 per diluted share, compared with GAAP net income of $33.5 million, or $0.42 per diluted share, for the second quarter of 2013.
Sign-up for - Health Net Reports Second Quarter 2014 GAAP Net Income of $120.9 Million, or $1.49 Per Diluted Share investment picks
ATLANTA , Aug.
Sign-up for - Aaron's, Inc. Announces CEO Ron Allen's Retirement investment picks
- Post-closing the transaction is expected to be immediately accretive to Platform's adjusted earnings and intrinsic value per share, pre-synergies MIAMI, Aug.
Sign-up for - Platform Specialty Products Corporation Announces Agreement to Acquire European-Based Agrochemicals Group Agriphar for 300 Million Euros investment picks
Zep Automotive, a unit of Zep Inc. (NYSE: ZEP), a leading consumable chemical packaged goods company that manufactures a wide variety of high-performance maintenance and cleaning chemicals, today announced the introduction of its reformulated, non-chlorinated 50-state compliant Brake Cleaner featuring an ultra-low VOC content with full-strength cleaning power.
Sign-up for - Zep Automotive® Introduces New Patent Pending Non-Chlorinated 50-State Compliant Brake Cleaner in Aerosol and Bulk Sizes investment picks
2014/8/6
Health Canada Approves ABRAXANE® Plus Gemcitabine for First-Line Treatment of Patients with Metastatic Pancreatic Cancer Canada NewsWire MISSISSAUGA, ON , August 6, 2014 /CNW/ - Health Canada has approved Pr ABRAXANE ® for Injectable Suspension (paclitaxel powder for injectable suspension) (nanoparticle, albumin-bound [nab ® ] paclitaxel) for first-line treatment of adult patients with metastatic pancreatic cancer.
Sign-up for 2014/8/6 - Health Canada Approves ABRAXANE® Plus Gemcitabine for First-Line Treatment of Patients with Metastatic Pancreatic Cancer investment picks
LAS VEGAS , Aug.
Sign-up for - Amarium Begins Ore Extraction at El Desvan Cobre investment picks
Two-part study to evaluate safety, pharmacokinetics and anti-itch effects in hemodialysis patients Top-line data expected in first half of 2015 SHELTON, Conn., Aug.
Sign-up for - Cara Therapeutics Initiates Proof-of-Concept Phase II Trial of I.V. CR845 in Uremic Pruritus investment picks
The GEO Group, Inc. (NYSE: GEO) ("GEO") announced that on August 5, 2014, its Board of Directors declared a quarterly cash dividend of $0.57 per share.
Sign-up for - The GEO Group Declares Quarterly Cash Dividend of $0.57 Per Share investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - Fox, Green Mountain on tap to report earnings after hours to - Celsus Therapeutics Plc Announces First Patient Enrolled in Phase II Trial of MRX-6 in Pediatric Atopic Dermatitis
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices